Difference between revisions of "Team:Georgia State/Design"

 
(88 intermediate revisions by 6 users not shown)
Line 29: Line 29:
 
                 <div class="site-header">
 
                 <div class="site-header">
 
                     <div class="logo">
 
                     <div class="logo">
                         <h1>Georgia State University</h1>
+
                         <h1>Design</h1>
 
                     </div>
 
                     </div>
  
Line 40: Line 40:
 
                             <div class="nav-collapse collapse">
 
                             <div class="nav-collapse collapse">
 
                                     <ul class="nav">
 
                                     <ul class="nav">
                                    <li><a href="https://2017.igem.org/Team:Georgia_State"  class="active">Home</a></li>
+
        <li><a href="https://2017.igem.org/Team:Georgia_State"  class="active">Home</a></li>
 +
        <li class="dropdown-submenu">
 +
            <a class="dropdown-toggle" data-toggle="dropdown">Team
 +
                <ul class="dropdown-menu">
 
                                     <li><a href="https://2017.igem.org/Team:Georgia_State/Team">Team</a></li>
 
                                     <li><a href="https://2017.igem.org/Team:Georgia_State/Team">Team</a></li>
                                     <li class="dropdown-submenu">
+
                                     <li><a href="https://2017.igem.org/Team:Georgia_State/Attributions">Attributions</a></li>
        <a href="https://2017.igem.org/Team:Georgia_State/Description" class="dropdown-toggle" data-toggle="dropdown">Project
+
                </ul>
                                          <ul class="dropdown-menu">
+
        </li>
                                          <li><a href="https://2017.igem.org/Team:Georgia_State/Design">Design</a></li>
+
 
                                          <li><a href="https://2017.igem.org/Team:Georgia_State/Results">Results</a></li>                                         
+
        <li class="dropdown-submenu">
                            <li><a href="https://2017.igem.org/Team:Georgia_State/Collaborations">Collaborations</a></li>
+
            <a class="dropdown-toggle" data-toggle="dropdown">Project
                                    <li><a href="https://2017.igem.org/Team:Georgia_State/Attributions">Attributions</a></li>
+
                <ul class="dropdown-menu">
                                                                                                                    </ul>
+
                         
                                                                            </li>
+
                                <li><a href=" https://2017.igem.org/Team:Georgia_State/Description">Description</a></li>
                                    <li class="dropdown-submenu">
+
                                <li><a href="https://2017.igem.org/Team:Georgia_State/Results">Results</a></li>                                         
                <a href="https://2017.igem.org/Team:Georgia_State/Parts" class="dropdown-toggle" data-toggle="dropdown">Parts
+
                                <li><a href="https://2017.igem.org/Team:Georgia_State/Collaborations">Collaborations</a></li>
                                          <ul class="dropdown-menu">
+
                                                                                                                                                         
                                      <li><a href="https://2017.igem.org/Team:Georgia_State/Design">Design</a></li>
+
                </ul>
                                      <li><a href="https://2017.igem.org/Team:Georgia_State/Contribution">Contribution</a></li>
+
          </li>
                                          <li><a href="https://2017.igem.org/Team:Georgia_State/Improve">Improvement</a></li>
+
       
                                                                                                        </ul>
+
        <li class="dropdown-submenu">
                                                                            </li>
+
            <a class="dropdown-toggle" data-toggle="dropdown">Parts
                                    <li><a href="https://2017.igem.org/Team:Georgia_State/Safety">Safety</a></li>
+
                <ul class="dropdown-menu">
                                    <li><a href="https://2017.igem.org/Team:Georgia_State/Notebook">Notebook</a></li>
+
                                <li><a href="https://2017.igem.org/Team:Georgia_State/Parts">Parts</a></li>
                                    <li class="dropdown-submenu">
+
                                <li><a href="https://2017.igem.org/Team:Georgia_State/Design">Design</a></li>    
      <a href="https://2017.igem.org/Team:Georgia_State/Engagement" class="dropdown-toggle" data-toggle="dropdown">Human Practices
+
                                <li><a href="https://2017.igem.org/Team:Georgia_State/Contribution">Contribution</a></li>
                                          <ul class="dropdown-menu">
+
                                <li><a href="https://2017.igem.org/Team:Georgia_State/Improve">Improvement</a></li>
                            <li><a href="https://2017.igem.org/Team:Georgia_State/HP/Silver">Silver</a></li>
+
              </ul>
                        <li><a href="https://2017.igem.org/Team:Georgia_State/HP/Gold_Integrated">Integrated and Gold</a></li>
+
          </li>
                            <li><a href="https://2017.igem.org/Team:Georgia_State/Engagement">Public Engagement</a></li>
+
        <li><a href="https://2017.igem.org/Team:Georgia_State/Safety">Safety</a></li>
                                                                            </ul>
+
       
                                                                            </li>
+
        <li class="dropdown-submenu">
                            <li><a href="https://igem.org/2017_Judging_Form?team=Georgia_State">Judging</a></li>
+
            <a class="dropdown-toggle" data-toggle="dropdown">Notebook
                                </ul>
+
                <ul class="dropdown-menu">
                            </div>
+
                              <li><a href="https://2017.igem.org/Team:Georgia_State/Notebook">Notebook</a></li>  
 +
                              <li><a href="https://2017.igem.org/Team:Georgia_State/Experiments">Experiments</a></li>
 +
                </ul>
 +
            </a>
 +
        </li>
 +
 
 +
        , <li class="dropdown-submenu">
 +
              <a class="dropdown-toggle" data-toggle="dropdown">Human Practices
 +
                <ul class="dropdown-menu">
 +
                          <li><a href="https://2017.igem.org/Team:Georgia_State/Engagement">Public Engagement</a></li>
 +
                          <li><a href="https://2017.igem.org/Team:Georgia_State/HP/Silver">Silver</a></li>
 +
                          <li><a href="https://2017.igem.org/Team:Georgia_State/HP/Gold_Integrated">Integrated and Gold</a>
 +
                              <ul><a href="https://2017.igem.org/Team:Georgia_State/HP/ASL">ASL Gallery</a></ul>
 +
                          </li>              
 +
                </ul>
 +
              </a>
 +
          </li>
 +
 
 +
          <li><a href="https://igem.org/2017_Judging_Form?team=Georgia_State">Judging</a></li>
 +
  </div>
 
<!--/.nav-collapse -->
 
<!--/.nav-collapse -->
 
                         </div>
 
                         </div>
Line 77: Line 99:
 
             <label>
 
             <label>
 
           <select class="selectnav"onChange="window.location.href=this.value">
 
           <select class="selectnav"onChange="window.location.href=this.value">
             <option value="https://2017.igem.org/Team:Georgia_State">Home</option>
+
             <option value="/Team:Georgia_State">Home</option>
             <option value="https://2017.igem.org/Team:Georgia_State">Team</option>
+
            <option value="/Team:Georgia_State/Team">Team</option>
             <option value="https://2017.igem.org/Team:Georgia_State">Project</option>
+
             <option value="/Team:Georgia_State/Attributions">Attributions</option>
             <option value="https://2017.igem.org/Team:Georgia_State">Parts</option>
+
            <option value="/Team:Georgia_State/Results">Results</option>
             <option value="https://2017.igem.org/Team:Georgia_State">Safety</option>
+
            <option value="/Team:Georgia_State/Collaborations">Collaborations</option>
             <option value="https://2017.igem.org/Team:Georgia_State">Human Practices</option>
+
             <option value="/Team:Georgia_State/Parts">Parts</option>
             <option value="https://2017.igem.org/Team:Georgia_State">Awards</option>
+
            <option value="/Team:Georgia_State/Description">Description</option>
             <option value="https://2017.igem.org/Team:Georgia_State">Notebook</option>
+
             <option value="/Team:Georgia_State/Design">Design</option>
 +
            <option value="/Team:Georgia_State/Contribution">Contribution</option>
 +
             <option value="/Team:Georgia_State/Improvement">Improve</option>
 +
            <option value="/Team:Georgia_State/Safety">Safety</option>
 +
             <option value="/Team:Georgia_State/Notebook">Notebook</option>
 +
            <option value="/Team:Georgia_State/Experiments">Experiments</option>
 +
             <option value="/Team:Georgia_State/Engagement">Public Engagement</option>
 +
            <option value="/Team:Georgia_State/HP/Silver">Silver</option>
 +
             <option value="/Team:Georgia_State/HP/Gold_Integrated">Gold and Integrated</option>
 +
            <option value="/Team:Georgia_State/HP/ASL">ASL Gallery</option>
 
             <option value="https://igem.org/2017_Judging_Form?team=Georgia_State">Judging</option>
 
             <option value="https://igem.org/2017_Judging_Form?team=Georgia_State">Judging</option>
 
           </select>
 
           </select>
Line 93: Line 124:
 
             </div>
 
             </div>
 
<!-- Menu End -->
 
<!-- Menu End -->
</html>
 
  
{{Georgia_State_sand}}
+
<div class="container">
<html>
+
                <div class="featured-heading">
 +
                    <h1><i><font style="text-transform: none;">"As soon as your brain starts telling you that you can't have a tree that is blue then you stop being able to paint trees."</font></i></h2>
 +
                    <h2>Steven Johnson</h4>
 +
                                    </div>
 +
            </div>
  
<h1 style="color:#1F618D; text-align: center; font-size: 36px; line-height: 38px;">Background</h1>
+
<div class="featured-content">
 +
<div class="container">
  
<h1 style="color:#ffffff; background-color:#1A5276;; -moz-border-radius: 15px; -webkit-border-radius: 12px; padding:12px; text-align: center; font-family: Trebuchet MS">What is Lipopolysaccharide?</h1>   
+
<br>
 +
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Limulus Factor C cDNA Design</h1>  <br>
 +
<br>
  
  
Endotoxin is a Lipopolysaccharide (LPS) it consists of a core oligosaccharide, O-antigen a glycan polymer and the lipid A. The lipid A is a phosphorylated glucosamine disaccharide with multiple fatty acids and is the cause for endotoxin toxicity. LPS are bacterial poisons and can impact numerous biological activities. When gram-negative bacteria enter the body a complement immune response is initiated. Once the cell wall and/or bacteria are destroyed a significant of endotoxins are released which can lead to endotoxemia the symptoms of which are vomiting, nausea, diarrhea, fever, disseminated intravascular coagulation, vascular collapse, organ failure and possibly death. Antibiotics will not inactivate the endotoxins, therefore detection of the endotoxin before they enter the body is prudent.<br>
+
<b>Limulus Factor C </b>is a relatively large protein (1020 amino acids), so the synthesis of its coding sequence presented a challenge. We determined that instead of trying to have the entire construct synthesized as one piece it would be more cost effective to build it in pieces. The coding sequence for Limulus Clotting Factor C (LFC) was designed as four contiguous blocks to be joined together via overlap extension PCR. Three of the four blocks were 800 bp long, the fourth block was 660 bp long. We designed primers for overlap extension PCR to join the g-blocks together into the final Factor C cDNA sequence. Primers were designed in both forward and reverse complement to the top and bottom strands of the blocks. For an example, the forward primer of Block 2 was created with a few base pairs from Block 1- 5’ top strand end. These base pairs were added to the beginning of the 5’ top strand to start amplification of Block 2- 5’ top strand. The reverse complement primer for Block 1 was created by taking a few base pairs from the end of the 3’ bottom strand of Block 1 and adding it to the 5’ bottom strand of Block 2. The goal of creating these primers is to create overhangs from the previous block to bind to the next block. During amplification the blocks would then be joined and extend the 5’ top strand and 3’ bottom strand of each block. Once all 4 blocks and a total of 8 primers were created, we began PCR amplification of Blocks 1 and 2 and then amplified Blocks 3 and 4. The fusion of the coupled blocks would then be fused together to make the final product, LFC Blocks 1-4 via overlap extension PCR. (LFC Blocks 1-4 fusion illustrated in the image below to the right).
 +
<br><br>
 +
<center><img src="https://static.igem.org/mediawiki/2017/2/25/T--Georgia_State--7.20OverlapFACTORCMAP.jpg"  alt="Horseshoe Crab in Aquarium" width="800" height="250" style="float:right;"></center>
  
 +
<center><img src= "https://static.igem.org/mediawiki/2017/d/d1/T--Georgia_State--7.20OverlapDIAGRAM.jpg" alt="Clotting Cascade" width="300" height="100" style="left;"></center>
 +
<br> <br>
 +
<b> PCR Overlap Extension</b>
 +
Due to the expense of purchasing the entire Factor C sequence as a new part and the opportunity to attempt a method that has never been done in the Georgia State University iGEM lab Factor C is planned to be synthesized via overlap extension PCR. A modified protocol written by Ichiro Matsumura was used. This method uses PCR to recombine DNA sequences instead of using restriction sites. By using a 3'-end primer that matches each template block and a 5'-end primer that matches a part of the block sequence and a part of the new block sequence. The two blocks can be recombined using DNA polymerase. The basic mechanism for overlap begins with a PCR to generate the two fragments (AB and CD)  that have ends modified by mispriming so that they have homologous regions. Through mixture, denaturation, and annealing the AB 3'-end will anneal onto the 3'-end of the bottom strand of the CD. Extension of the overlap product is used to form the recombinant product (the overlapping ends of the fragments are created by primers b and c while a and d match the individual fragments). The method can be repeated to add together more than two DNA fragments.
 +
The image above and to the left is a figure to illustrate the mechanism described above.
  
<div style="color:#ffffff; background-color:#1A5276;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">What do Horseshoe crabs have to do with endotoxin?
+
<br> <br>
</div>   
+
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Human Chorionic Gonadotropin</h1<br><br>
  
 +
<center><img src="https://static.igem.org/mediawiki/2017/f/f5/T--Georgia_State--recombiantHCGPCRsufixpreffix_.jpg"  alt="Horseshoe Crab in Aquarium" width="800" height="250" style="float:center;"></center><br><br>
 +
When designing this part we used the recombinant<b> human chorionic gonadotropin </b> cDNA sequence, sequenced by The National Institutes of Health Mammalian Gene Collection (MGC) Program . While the same amino acids are present, the cDNA sequence is altered. To detect the activation of Factor C autocatalysis, a hCG-beta subunit sequence component was a necessary addition to our final Factor C cDNA sequence. Similar to the primers designed for Factor C, we designed a forward and a reverse complement primer with iGEM prefix and suffix to join Block 4 of Factor C and Block 5 of hCG-beta subunit together. For our idea of a detection system, we plan to use a pregnancy test to detect the recombinant hCG-beta subunit once Factor C is activated.
 +
<br>
  
<img src= "https://static.igem.org/mediawiki/2017/c/cf/T--Georgia_State--horseshoebranfromaquarium.jpg" alt="Horseshoe Crab in Aquarium" width="200" height="200">
+
<br>
 +
<br><br>
  
 +
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Factor C-hCG Fusion </h1> <br>
 +
<center><img src="https://static.igem.org/mediawiki/2017/c/c4/T--Georgia_State--FactorCfusion.jpg"  alt="Horseshoe Crab in Aquarium" width="800" height="250" style="float:right;"></center>
 +
The basic mechanism for overlap begins with a PCR to generate two fragments (Block 1 and Block 2) that have ends modified by mispriming so that they have homologous regions. Through mixture, denaturation, and annealing of Block 1 5'-end of the top strand will anneal onto the 3'-end of the bottom strand of Block 2. Extension of the overlap product is used to form the recombinant product (the overlapping ends of the fragments are created by the forward primers and reverse complement primers to match the individual fragments). The method can be repeated to add together more than two DNA fragments (Block 3 and Block 4 + hCG-beta subunit). Together, all 5 g-blocks and a total of 10 primers would be joined via overlap extension PCR. If this joining of LFC blocks 1-4 and hCG-beta subunit block 5 is successful, the final product of <b>Limulus Clotting Factor C + hCG-beta subunit sequence</b> would be used as our complete detection system.
 +
<br><br>
  
 
 
<b> Limulus polyphemus </b> (Atlantic horseshoe crab) is protected against infection by their immune system and blood coagulation system. They use hemocyanin to carry oxygen instead of hemoglobin. The blue color of their blood is due to the presence of copper in hemocyanin. The amebocytes (blood cells) are similar to white blood cells. Inside the amebocytes are proteins that are released in response to unwanted organisms like gram-negative bacteria. These proteins bind to and inactivate endotoxin. Assistance in wound control is moderated by components of their blood which prevent bleeding and form a physical barrier against additional infection.
 
In the presence of endotoxin, a clotting cascade is invoked to activate the proclotting enzyme which is used to transform coagulogen into coagulin. The zymogen Factor C is a glycoprotein that is 123kD, and the only enzyme that is endotoxin sensitive. It consists of an H chain (80kD) and L chain (43kD). Factor C activates in the presence of LPS and undergoes autocatalysis, the phenylalanine- isoleucine bond on the L chain is cleaved resulting in a B chain (34kD) and an A chain (8.5 kD). Factor C then activates Factor B which activates the proclotting enzyme. An activated proclotting enzyme is called the clotting enzyme which converts coagulogen into coagulin.
 
<br><br>
 
 
Although endometriosis can affect any uterus-owning person after puberty, it's often thought to be more prevalent in older women; this is a myth. Endometriosis can affect a girl immediately after puberty, but this myth may have spread because of the immense delay between the onset of symptoms and an accurate diagnosis. Affected women wait, on average, between 7 and 10 years for an accurate diagnosis for their chronic pain.
 
 
<br><br><br>
 
<h1 style="color:#ffffff; background-color:#1A5276;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">How is endometriosis diagnosed and treated?</h1> 
 
 
The diagnosis process begins with suspicion based on a description of symptoms like extended, painful menses and gastrointestinal discomfort. At this point, a woman might be prescribed low-level hormonal therapy in the form of a contraceptive pill, or be told to simply take pain relieving medications like ibuprofen. If painful symptoms persist, the situation becomes more complicated. The only totally accurate diagnostic method for endometriosis is a combination of laparoscopic surgery, to get sight of ectopic lesions of endometrial tissue, followed by obtaining a sample of that tissue and then sending it for pathologic confirmation in a lab. Laparoscopic surgery is no small procedure, and symptoms of endometriosis often very closely follow puberty. A doctor is thus unlikely to send a 14-year-old girl for diagnostic surgery, which may turn up nothing, when there are a variety of other, more easily diagnosed conditions that may also cause chronic abdominal pain. Beyond that, the steps toward laparoscopic diagnosis aren't always taken because providers underestimate the symptoms that a patient is presenting to them. Unfortunately, there is a stigma around menstrual disorders that is hard to get past.<br><br>
 
 
This leads to the average 7- to 10- year wait between the onset of symptoms and a final diagnosis of endometriosis. However, the current diagnostic method is also lacking in accuracy because it assumes that endometriotic lesions will always be visible when in fact endometriosis can exist microscopically and still cause pain. <br><br>
 
 
Once endometriosis is diagnosed, the most effective treatment is deep tissue excision to remove the growths of ectopic endometrium. Unfortunately, small lesions can be missed, causing further pain and requiring more surgery. Until recently, total hysterectomy (removal of uterus and ovaries) was used as a treatment for endometriosis, but it has not been proven effective and is going out of practice, as pain from endometriosis would often continue even after this extreme surgery. <br><br>
 
 
We at MIT iGEM believe that if endometriosis could be diagnosed sooner, it would not give the disease as much time to progress, making treatment more effective with fewer surgeries, and it would alleviate years of chronic pain and distress from not knowing the cause. This led us to find a number of proven molecular markers of endometriosis that persist in endometrial biopsies, all of which could be sensed with synthetic biological tools to give a diagnosis in a matter of days.
 
 
<br><br>
 
<br><br>
  
<h1 style="color:#ffffff; background-color#1A5276;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">How can synthetic biology help?</h1> 
 
  
A major hallmark of endometriosis is the rise of progesterone resistance in both ectopic and eutopic endometrial cells, which means both the misplaced growths of cells <i>and</i> the properly placed endometrial tissue lining the uterus. The tissue is, however, very sensitive to the presence of estradiol, the most active form of the hormone estrogen. With this in mind, we designed a pair of genetic promoter regions that can increase the expression of a gene based on the presence of progesterone or estradiol. Synthetic genetic circuits using Boolean (binary) logic can then implement these promoters to identify estrogen sensitivity and progesterone resistance in a cell culture.<br><br>
 
  
Another factor that can identify cells affected by endometriosis is a difference in microRNA (miRNA) levels. miRNA is a form of single stranded RNA that is present in all mammalian cells, but the nucleotide codes and the activities of these strands differ between cell types and cell states. Scientists like Asgi Fazleabas have studied differences in miRNA profiles between the eutopic endometrium in a healthy state compared to a disease state and found a number of miRNA that have different activity levels between the two states. We continued this research in model cell lines to find candidates that could be used in a diagnostic tool under changing hormone conditions. <br><Br>
 
  
Endometrial tissue normally functions to respond to a hormone cycle that regulates menstruation, facing estrogen and then progesterone. miRNA levels may change over this cycle as well. Because of this, we needed a tool that would allow us to consider both phases in the cycle. We found that tool in an irreversible recombinase, TP901, which needed to be characterized in more detail in mammalian cells. This part of the project involved better characterizing a part that existed in the Registry already, that part being TP901. We provided all new characterization of the protein and its activity in mammalian cells.
+
<ol style="font-size: 8pt;">
 +
<br>
  
<br><br>
+
<a href="https://2017.igem.org/Team:Georgia_State"><h1 style="color:#ffffff; background-color:#A9CCE3; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Back to Home</h1> </a><br><br>
 
+
<a href="https://2016.igem.org/Team:MIT/Experiments"><h1 style="color:#ffffff; background-color:#F20253;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Next: Experimental Design</h1> </a>
+
<ul class="img-home">
+
<li>
+
    <a href="https://2016.igem.org/Team:MIT/Experiments/Promoters">
+
      <img src="https://static.igem.org/mediawiki/2016/1/16/T--MIT--synpromobutton.svg" alt="Promoters" >
+
      <span class="text-content"><span><br><br><br><br><br><br><br>We created new, synthetic promoters to respond to this disease marker<br><br></span></span>
+
    </a>
+
</li>
+
<li> 
+
    <a href="https://2016.igem.org/Team:MIT/Experiments/miRNA">
+
      <img src="https://static.igem.org/mediawiki/2016/8/89/T--MIT--miRNAsensorsbutton.svg" alt="miRNA" >
+
      <span class="text-content"><span><br><br><br><br><br><br><br>We characterized microRNA profiles in model cells under varying conditions<br><br></span></span>
+
    </a>
+
  </li>
+
<li> 
+
    <a href="https://2016.igem.org/Team:MIT/Experiments/Recombinases">
+
      <img src="https://static.igem.org/mediawiki/2016/e/e2/T--MIT--recombinasesbutton.svg" alt="Recombinases" >
+
      <span class="text-content"><span><br><br><br><br><br><br>We characterized a serine integrase, TP901, that could give a genetic circuit memory across a cycle<br><br></span></span>
+
    </a>
+
  </li>
+
</ul>
+
<br><br>
+
<a href="https://2016.igem.org/Team:MIT"><h1 style="color:#ffffff; background-color:#F20253;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Back to Home</h1> </a>
+
 
+
<ol style="font-size: 8pt;">
+
 
<b>References</b><br>
 
<b>References</b><br>
- - - C. Nezhat et al 2012. <i>Endometriosis: Ancient disease, ancient treatments.</i><a href="http://www.nezhat.org/file/Endometriosis-Article.pdf">http://www.nezhat.org/file/Endometriosis-Article.pdf</a> <br>
 
 
- - - <i>Do you have Endo? </i>Endometriosis Research Center. <a href="https://www.endocenter.org/do-you-have-endo/">https://www.endocenter.org/do-you-have-endo/</a> <br>
 
  
- - - <i>FAQ.</i> MIT Center for Gynepathology Research. <a href="http://web.mit.edu/cgr/faq---links.html">http://web.mit.edu/cgr/faq---links.html</a><br>
+
- - -Horton, R. M., Cai, Z., Ho, S. N., Pease, L. R., & Mayo Clinic. (2013). <i>Gene Splicing by Overlap Extension: Tailor-Made Genes Using the Polymerase Chain Reaction. BioTechniques, 54(3), 129-130 . doi:10.2144/000114017</i><a https://www.biotechniques.com/multimedia/archive/00190/BTN_A_000114017_O_190204a.pdf ">https://www.biotechniques.com/multimedia/archive/00190/BTN_A_000114017_O_190204a.pdf </a> <br>
  
- - - <i>Altered expression of microRNA-451 in eutopic endometrium of baboons (Papio anubis) with endometriosis.</i> Joshi NR <i>et al.</i> 2015.<br> NCBI <a href="https://www.ncbi.nlm.nih.gov/pubmed/26370665">https://www.ncbi.nlm.nih.gov/pubmed/26370665</a><br>
 
  
- - - <i>Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women<br> with Endometriosis</i> R. O. Burney <i> et all</i> 2009. Endocrinology <a href="http://press.endocrine.org/doi/full/10.1210/en.2006-1692">http://press.endocrine.org/doi/full/10.1210/en.2006-1692</a><br>
 
  
- - - <i> What is Endometriosis?. </i>Endometriosis Foundation of America. <a href="http://www.endofound.org/endometriosis">http://www.endofound.org/endometriosis</a><br>
+
- - - <i>CGB protein [Homo sapiens] - Protein - NCBI. (2003, October 7).<br> Retrieved July 7 2017, from  </i> <a href="https://www.ncbi.nlm.nih.gov/protein/26996824?report=genbank&log%24=protalign&blast_rank=1&RID=PU2MZS8Z014"> https://www.ncbi.nlm.nih.gov/protein/26996824?report=genbank&log%24=protalign&blast_rank=1&RID=PU2MZS8Z014</a><br>
  
</ol>
+
- - - <i>P28175 (LFC_TACTR) Tachypleus tridentatus (Japanese horseshoe crab). (n.d.). Retrieved June 21, 2017, from
</html>
+
</i> <br> <a href=" https://swissmodel.expasy.org/repository/uniprot/P28175?csm=5BC2864C6715289B"> https://swissmodel.expasy.org/repository/uniprot/P28175?csm=5BC2864C6715289B</a><br>
 +
</div>
 +
</div>
 +
<br>
 +
</div>

Latest revision as of 03:37, 2 November 2017